Anti-ageing Medicine: Myths and Chancesvdf Hochschulverlag AG, 2008 - 304 páginas The 21st century technological development is revolutionizing medicine and health care, bringing new hopes to human suffering by offering cures and treatments which were unthinkable a few decades ago. This is where anti-ageing medicine finds its niche. Anti-ageing medicine aims at slowing, arresting, and reversing phenomena associated with ageing by merging biotechnological innovation and engineered solutions. Ideally, by means of the newest medical technology, the "body machinery" should be kept fit and at peak performance all life long. Early detection of age-related dysfunction should thus be "fixed" at any age with interventions such as metabolic fine tuning, enhancement, regeneration, restoration or replacement of "body parts" (i.e. organs, skin, bone or muscle). It covers a vast array of domains: from cell therapy to pharmaceutical interventions, from bio-surgery to aesthetic surgery, from human enhancement to fortified food, from smart housing and robots to toxic-free environments. Anti-ageing medicine holds promises but also significant risks and safety issues which are addressesd in this book. It presents the latest scientific evidence on what works or does not work. It also provides public policy recommendations to ensure the protection of consumers and their rights while encouraging research and development. This book is intended for academics, health professionals, business persons, consumers and policy-makers interested in the latest evidence and ethical issues about anti-ageing medicine. |
Dentro del libro
Resultados 1-5 de 10
Página vi
... Botox – Botulinum toxin Type A .................................................................... 139 b. Mesotherapy: The New Cellulite Treatment .................
... Botox – Botulinum toxin Type A .................................................................... 139 b. Mesotherapy: The New Cellulite Treatment .................
Página 139
... Botox – Botulinum toxin Type A Background : Botulinum Toxin Type A ( Botox Cosmetic ) is a protein complex produced by the bacterium Clostridium botulinum.44 It is injected in the body and is effective in weakening or paralyzing certain ...
... Botox – Botulinum toxin Type A Background : Botulinum Toxin Type A ( Botox Cosmetic ) is a protein complex produced by the bacterium Clostridium botulinum.44 It is injected in the body and is effective in weakening or paralyzing certain ...
Página 140
... botulinum toxin type A (BTX-A) across all common therapeutic indications demonstrated that the formulation of BTX-A is safe and has a favourable safety and tolerability profile across a broad spectrum of therapeutic uses (Naumann and ...
... botulinum toxin type A (BTX-A) across all common therapeutic indications demonstrated that the formulation of BTX-A is safe and has a favourable safety and tolerability profile across a broad spectrum of therapeutic uses (Naumann and ...
Página 142
... Botulinum toxin , known as Botox , is a drug , not a cosmetic . However , people from all social classes request Botox injection . As it is effective ( for a few months ) , there is a foreseeable increase in much younger and much older ...
... Botulinum toxin , known as Botox , is a drug , not a cosmetic . However , people from all social classes request Botox injection . As it is effective ( for a few months ) , there is a foreseeable increase in much younger and much older ...
Página 164
... toxin: Botulinum toxin is an exotoxin produced by the bacterium Clostridium botulinum. It is considered to be the most potent biological toxin in nature. Since its introduction into clinical medicine three decades ago, it has become a ...
... toxin: Botulinum toxin is an exotoxin produced by the bacterium Clostridium botulinum. It is considered to be the most potent biological toxin in nature. Since its introduction into clinical medicine three decades ago, it has become a ...
Términos y frases comunes
AAM market AAM products acid age-related ageing process Alzheimer’s disease anti-ageing interventions anti-ageing medicine anti-ageing research antioxidant benefits better ageing biogerontologists biological biomarkers body Botox botulinum toxin brain cancer centenarians chelation therapy clinical cognitive consumers cosmetic decline devices DHEA dietary supplements disability disease effects elderly enhancement ethical evidence expectancy function gene therapy genes genetic genomics geriatric groups healthy ageing human improve increase individual issues lifestyle live longevity maximum life span mental health mesotherapy metabolic muscle nutrition old age older persons patients perspective physical activity population potential practice practitioners prevention problems process of ageing programme promotion recommendations reliability theory risk factors robots scientific scientists social society specific statins stem cell strategies Stuckelberger studies successful ageing surgery Swiss Switzerland TA-SWISS testing testosterone Theory of Ageing therapy tissue treatment vitamin vitamin E women